Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar;76(4):498-508.
doi: 10.1111/his.14014. Epub 2020 Feb 18.

The role of glutaminase in cancer

Brendah K Masisi  1 , Rokaya El Ansari  1 , Lutfi Alfarsi  1 , Emad A Rakha  1 , Andrew R Green  1 , Madeleine L Craze  1
Affiliations
Review

The role of glutaminase in cancer

Brendah K Masisi et al. Histopathology. 2020 Mar.

Abstract

Increased glutamine metabolism (glutaminolysis) is a hallmark of cancer and is recognised as a key metabolic change in cancer cells. Breast cancer is a heterogeneous disease with different morphological and molecular subtypes and responses to therapy, and breast cancer cells are known to rewire glutamine metabolism to support survival and proliferation. Glutaminase isoenzymes (GLS and GLS2) are key enzymes for glutamine metabolism. Interestingly, GLS and GLS2 have contrasting functions in tumorigenesis. In this review, we explore the role of glutaminase in cancer, primarily focusing on breast cancer, address the role played by oncogenes and tumour suppressor genes in regulating glutaminase, and discuss current therapeutic approaches to targeting glutaminase.

Keywords: breast cancer; cancer; glutaminase; glutamine; metabolism; subtypes.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Boroughs LK, DeBerardinis RJ. Metabolic pathways promoting cancer cell survival and growth. Nat. Cell Biol. 2015; 17; 351.
    1. Dang CV, Hamaker M, Sun P, Le A, Gao P. Therapeutic targeting of cancer cell metabolism. J. Mol. Med. 2011; 89; 205-212.
    1. Liberti MV, Locasale JW. The warburg effect: how does it benefit cancer cells? Trends Biochem. Sci. 2016; 41; 211-218.
    1. Hensley CT, Wasti AT, DeBerardinis RJ. Glutamine and cancer: cell biology, physiology, and clinical opportunities. J. Clin. Invest. 2013; 123; 3678-3684.
    1. Fuchs BC, Bode BP. Stressing out over survival: glutamine as an apoptotic modulator. J. Surg. Res. 2006; 131; 26-40.

LinkOut - more resources